About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« I'll Get Right On That For You, Professor | Main | Plavix vs. Effient »

November 18, 2009

More For the Blogroll

Email This Entry

Posted by Derek

Two more blogs that I've forgotten to add are now on the blogroll: Pharma Conduct and Chemical Space. Welcome!

Update: oh yeah, Pharmalot returns, too!

Comments (5) + TrackBacks (0) | Category: Blog Housekeeping


1. HelicalZz on November 18, 2009 1:50 PM writes...

But not the return of Pharmalot?


Permalink to Comment

2. Hap on November 18, 2009 2:16 PM writes...

The post of 12 October points at Pharmalot. I don't know why I can't find it in the blogroll, though.

Permalink to Comment

3. Lucifer on November 19, 2009 1:16 AM writes...

Vytorin, Lipitor or Generic Are Same in Analysis

Nov. 18 (Bloomberg) -- Cholesterol pills Vytorin from Merck & Co. and Lipitor from Pfizer Inc. worked no better than simvastatin, a cheaper generic medicine, at keeping patients out of the hospital for heart attacks or stroke, a study found.

Researchers with UnitedHealth Group Inc.’s pharmacy benefits unit Prescription Solutions analyzed medical claims of 30,000 patients taking one of the three drugs. They found no difference in rates of heart attacks or stroke among the three groups, according to data presented today at the American Heart Association meeting in Orlando, Florida.

The analysis suggests that heart patients may fare just as well by taking the least-expensive cholesterol-lowering pill. Simvastatin costs 84 cents for a 40 milligram dose, compared with $3.91 for the same dosage of Lipitor and $3.74 for Vytorin. A study last year showed that Vytorin worked no better than simvastatin at reopening arteries and a separate study reported this week found that Abbott Laboratories’ Niaspan may be superior to Vytorin in certain patients.

Permalink to Comment

4. Eric Milgram on November 19, 2009 12:30 PM writes...

Thanks for the mention! I'm honored.

Permalink to Comment

5. David P on November 19, 2009 4:27 PM writes...

Thanks for adding my blog, Derek! Like Eric, I am honored.

Permalink to Comment


Remember Me?


Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry